Home » Life & Medical » Global Urological Cancer Drugs Market 2021: Global Status & Forecast by Geography, Type & Application (2017-2027)

Global Urological Cancer Drugs Market 2021: Global Status & Forecast by Geography, Type & Application (2017-2027)

  83 Pages     Life & Medical  

Available Formats      

Report ID: 76552
Published By: 99Strategy

Summary

The Global Urological Cancer Drugs Market is estimated to reach xxx million USD in 2021 and projected to grow at the CAGR of xx% during the 2022-2027. The report analyses the global Urological Cancer Drugs market, the market size and growth, as well as the major market participants.

The analysis includes market size, upstream situation, market segmentation, price & cost and industry environment. In addition, the report outlines the factors driving industry growth and the description of market channels. The report begins from overview of industrial chain structure, and describes the upstream. Besides, the report analyses market size and forecast in different geographies, type and end-use segment, in addition, the report introduces market competition overview among the major companies and companies profiles, besides, market price and channel features are covered in the report.

Key Regions

  • Asia Pacific
  • North America
  • Europe
  • South America
  • Middle East & Africa

Key Companies

  • Novartis
  • Pfizer
  • Johnson & Johnson
  • AstraZeneca
  • Astellas
  • Bristol-Myers Squibb
  • Abbott Laboratories
  • Celgene Corporation
  • Dendreon Corporation
  • Ferring Pharmaceuticals
  • GlaxoSmithKline
  • Indevus Pharmaceuticals Inc
  • Ipsen
  • Roche Healthcare
  • Sanofi S.A.
  • Tolmar Inc

Key Product Type

  • Xofigo (Radium Ra 223 Dichloride)
  • Jevtana (Cabazitaxel)
  • Inlyta (Axitinib)
  • Votrient (Pazopanib Hydrochloride)
  • Sutent (Sunitinib Malate)
  • Zytiga (Abiraterone Acetate)
  • Xtandi (Enzalutamide)
  • Opdivo (Nivolumab)
  • Provenge (Sipuleucel-T)

Market by Application

  • Prostate Cancer
  • Bladder Cancer
  • Kidney Cancer
  • Testicular Cancer

Main Aspects covered in the Report

  • Overview of the Urological Cancer Drugs market including production, consumption, status & forecast and market growth
  • 2017-2021 historical data and 2022-2027 market forecast
  • Geographical analysis including major countries
  • Overview the product type market including development
  • Overview the end-user market including development

If you have any special requirements, please let us know and we will offer you the report as you want.

Table Of Contents

1 Industrial Chain Overview

1.1 Urological Cancer Drugs Industry

1.1.1 Overview

Figure Urological Cancer Drugs Picture List

1.1.2 Characteristics of Urological Cancer Drugs

1.2 Upstream

1.2.1 Major Materials

1.2.2 Manufacturing Overview

1.3 Product List By Type

1.3.1 Xofigo (Radium Ra 223 Dichloride)

1.3.2 Jevtana (Cabazitaxel)

1.3.3 Inlyta (Axitinib)

1.3.4 Votrient (Pazopanib Hydrochloride)

1.3.5 Sutent (Sunitinib Malate)

1.3.6 Zytiga (Abiraterone Acetate)

1.3.7 Xtandi (Enzalutamide)

1.3.8 Opdivo (Nivolumab)

1.3.9 Provenge (Sipuleucel-T)

1.4 End-Use List

1.4.1 Demand in Prostate Cancer

1.4.2 Demand in Bladder Cancer

1.4.3 Demand in Kidney Cancer

1.4.4 Demand in Testicular Cancer

1.5 Global Market Overview

1.5.1 Global Market Size and Forecast, 2017-2027

Figure Global Market Size and Forecast with Growth Rate, 2017-2027

1.5.2 Global Market Size and Forecast by Geography with CAGR, 2017-2027

Table Global Market Size and Forecast by Geography with Growth Rate, 2017-2027

1.5.3 Global Market Size and Forecast by Product Type with CAGR, 2017-2027

Table Global Market Size and Forecast by Type with Growth Rate, 2017-2027

1.5.4 Global Market Size and Forecast by End-Use with CAGR, 2017-2027

Table Global Market Size and Forecast by End-Use with Growth Rate, 2017-2027

2 Global Production & Consumption by Geography

2.1 Global Production & Consumption

2.1.1 Global Production

Figure Global Production Volume Status and Growth Rate, 2017-2021, in Volume

Table Global Production Volume Status and Growth Rate by Geography, 2017-2021, in Volume

Figure Global Production Amount Status and Growth Rate, 2017-2021, in Million USD

Table Global Production Amount Status and Growth Rate by Geography, 2017-2021, in Million USD

2.1.2 Global Consumption

Figure Global Market Volume and Growth Rate, 2017-2021, in Volume

Table Global Market Volume and Growth Rate by Geography, 2017-2021, in Volume

Figure Global Market Amount and Growth Rate, 2017-2021, in Million USD

Table Global Market Amount and Growth Rate by Geography, 2017-2021, in Million USD

2.2 Geographic Production & Consumption

2.2.1 Production

2.2.1.1 Asia-Pacific

Figure Asia-Pacific Production Volume Status and Growth Rate, 2017-2021, in Volume

Table Asia-Pacific Production Volume Status and Growth Rate by Region, 2017-2021, in Volume

Figure Asia-Pacific Production Amount Status and Growth Rate, 2017-2021, in Million USD

Table Asia-Pacific Production Amount Status and Growth Rate by Region, 2017-2021, in Million USD

2.2.1.2 North America

Figure North America Production Volume Status and Growth Rate, 2017-2021, in Volume

Table North America Production Volume Status and Growth Rate by Region, 2017-2021, in Volume

Figure North America Production Amount Status and Growth Rate, 2017-2021, in Million USD

Table North America Production Amount Status and Growth Rate by Region, 2017-2021, in Million USD

2.2.1.3 South America

Figure South America Production Volume Status and Growth Rate, 2017-2021, in Volume

Table South America Production Volume Status and Growth Rate by Region, 2017-2021, in Volume

Figure South America Production Amount Status and Growth Rate, 2017-2021, in Million USD

Table South America Production Amount Status and Growth Rate by Region, 2017-2021, in Million USD

2.2.1.4 Europe

Figure Europe Production Volume Status and Growth Rate, 2017-2021, in Volume

Table Europe Production Volume Status and Growth Rate by Region, 2017-2021, in Volume

Figure Europe Production Amount Status and Growth Rate, 2017-2021, in Million USD

Table Europe Production Amount Status and Growth Rate by Region, 2017-2021, in Million USD

2.2.1.5 Middle East & Africa

Figure Middle East & Africa Production Volume Status and Growth Rate, 2017-2021, in Volume

Table Middle East & Africa Production Volume Status and Growth Rate by Region, 2017-2021, in Volume

Figure Middle East & Africa Production Amount Status and Growth Rate, 2017-2021, in Million USD

Table Middle East & Africa Production Amount Status and Growth Rate by Region, 2017-2021, in Million USD

2.2.2 Consumption

2.2.2.1 Asia-Pacific

Figure Asia-Pacific Market Volume and Growth Rate, 2017-2021, in Volume

Table Asia-Pacific Market Volume and Growth Rate by Region, 2017-2021, in Volume

Figure Asia-Pacific Market Amount and Growth Rate, 2017-2021, in Million USD

Table Asia-Pacific Market Amount and Growth Rate by Region, 2017-2021, in Million USD

2.2.2.2 North America

Figure North America Market Volume and Growth Rate, 2017-2021, in Volume

Table North America Market Volume and Growth Rate by Region, 2017-2021, in Volume

Figure North America Market Amount and Growth Rate, 2017-2021, in Million USD

Table North America Market Amount and Growth Rate by Region, 2017-2021, in Million USD

2.2.2.3 South America

Figure South America Market Volume and Growth Rate, 2017-2021, in Volume

Table South America Market Volume and Growth Rate by Region, 2017-2021, in Volume

Figure South America Market Amount and Growth Rate, 2017-2021, in Million USD

Table South America Market Amount and Growth Rate by Region, 2017-2021, in Million USD

2.2.2.4 Europe

Figure Europe Market Volume and Growth Rate, 2017-2021, in Volume

Table Europe Market Volume and Growth Rate by Region, 2017-2021, in Volume

Figure Europe Market Amount and Growth Rate, 2017-2021, in Million USD

Table Europe Market Amount and Growth Rate by Region, 2017-2021, in Million USD

2.2.2.5 Middle East & Africa

Figure Middle East & Africa Market Volume and Growth Rate, 2017-2021, in Volume

Table Middle East & Africa Market Volume and Growth Rate by Region, 2017-2021, in Volume

Figure Middle East & Africa Market Amount and Growth Rate, 2017-2021, in Million USD

Table Middle East & Africa Market Amount and Growth Rate by Region, 2017-2021, in Million USD

3 Major Manufacturers Introduction

3.1 Manufacturers Overview

Table Major Manufacturers Headquarters and Contact Information

Table Major Manufacturers Capacity List in 2021

3.2 Manufacturers List

3.2.1 Novartis Overview

Table Novartis Overview List

3.2.1.1 Product Specifications

3.2.1.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)

Table Urological Cancer Drugs Business Operation of Novartis (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)

3.2.1.3 Recent Developments

3.2.1.4 Future Strategic Planning

3.2.2 Pfizer Overview

Table Pfizer Overview List

3.2.2.1 Product Specifications

3.2.2.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)

Table Urological Cancer Drugs Business Operation of Pfizer (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)

3.2.2.3 Recent Developments

3.2.2.4 Future Strategic Planning

3.2.3 Johnson & Johnson Overview

Table Johnson & Johnson Overview List

3.2.3.1 Product Specifications

3.2.3.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)

Table Urological Cancer Drugs Business Operation of Johnson & Johnson (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)

3.2.3.3 Recent Developments

3.2.3.4 Future Strategic Planning

3.2.4 AstraZeneca Overview

Table AstraZeneca Overview List

3.2.4.1 Product Specifications

3.2.4.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)

Table Urological Cancer Drugs Business Operation of AstraZeneca (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)

3.2.4.3 Recent Developments

3.2.4.4 Future Strategic Planning

3.2.5 Astellas Overview

Table Astellas Overview List

3.2.5.1 Product Specifications

3.2.5.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)

Table Urological Cancer Drugs Business Operation of Astellas (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)

3.2.5.3 Recent Developments

3.2.5.4 Future Strategic Planning

3.2.6 Bristol-Myers Squibb Overview

Table Bristol-Myers Squibb Overview List

3.2.6.1 Product Specifications

3.2.6.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)

Table Urological Cancer Drugs Business Operation of Bristol-Myers Squibb (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)

3.2.6.3 Recent Developments

3.2.6.4 Future Strategic Planning

3.2.7 Abbott Laboratories Overview

Table Abbott Laboratories Overview List

3.2.7.1 Product Specifications

3.2.7.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)

Table Urological Cancer Drugs Business Operation of Abbott Laboratories (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)

3.2.7.3 Recent Developments

3.2.7.4 Future Strategic Planning

3.2.8 Celgene Corporation Overview

Table Celgene Corporation Overview List

3.2.8.1 Product Specifications

3.2.8.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)

Table Urological Cancer Drugs Business Operation of Celgene Corporation (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)

3.2.8.3 Recent Developments

3.2.8.4 Future Strategic Planning

3.2.9 Dendreon Corporation Overview

Table Dendreon Corporation Overview List

3.2.9.1 Product Specifications

3.2.9.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)

Table Urological Cancer Drugs Business Operation of Dendreon Corporation (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)

3.2.9.3 Recent Developments

3.2.9.4 Future Strategic Planning

3.2.10 Ferring Pharmaceuticals Overview

Table Ferring Pharmaceuticals Overview List

3.2.10.1 Product Specifications

3.2.10.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)

Table Urological Cancer Drugs Business Operation of Ferring Pharmaceuticals (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)

3.2.10.3 Recent Developments

3.2.10.4 Future Strategic Planning

3.2.11 GlaxoSmithKline Overview

Table GlaxoSmithKline Overview List

3.2.11.1 Product Specifications

3.2.11.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)

Table Urological Cancer Drugs Business Operation of GlaxoSmithKline (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)

3.2.11.3 Recent Developments

3.2.11.4 Future Strategic Planning

3.2.12 Indevus Pharmaceuticals Inc Overview

Table Indevus Pharmaceuticals Inc Overview List

3.2.12.1 Product Specifications

3.2.12.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)

Table Urological Cancer Drugs Business Operation of Indevus Pharmaceuticals Inc (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)

3.2.12.3 Recent Developments

3.2.12.4 Future Strategic Planning

3.2.13 Ipsen Overview

Table Ipsen Overview List

3.2.13.1 Product Specifications

3.2.13.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)

Table Urological Cancer Drugs Business Operation of Ipsen (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)

3.2.13.3 Recent Developments

3.2.13.4 Future Strategic Planning

3.2.14 Roche Healthcare Overview

Table Roche Healthcare Overview List

3.2.14.1 Product Specifications

3.2.14.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)

Table Urological Cancer Drugs Business Operation of Roche Healthcare (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)

3.2.14.3 Recent Developments

3.2.14.4 Future Strategic Planning

3.2.15 Sanofi S.A. Overview

Table Sanofi S.A. Overview List

3.2.15.1 Product Specifications

3.2.15.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)

Table Urological Cancer Drugs Business Operation of Sanofi S.A. (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)

3.2.15.3 Recent Developments

3.2.15.4 Future Strategic Planning

3.2.16 Tolmar Inc Overview

Table Tolmar Inc Overview List

3.2.16.1 Product Specifications

3.2.16.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)

Table Urological Cancer Drugs Business Operation of Tolmar Inc (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)

3.2.16.3 Recent Developments

3.2.16.4 Future Strategic Planning

4 Market Competition Pattern

4.1 Market Size and Sketch

Figure Global Market Size and Growth Rate, 2017-2021, in Volume

Figure Global Market Size and Growth Rate, 2017-2021, in Million USD

Figure Global Competition Sketch Overview

4.2 Company Market Share

4.2.1 Global Production by Major Manufacturers

Table Global Production Volume List by Manufacturers, 2017-2021, in Volume

Table Global Production Volume Share List by Manufacturers, 2017-2021, in Volume

Figure Global Production Volume Share by Manufacturers in 2021, in Volume

Table Global Production Amount List by Manufacturers, 2017-2021, in Million USD

Table Global Production Amount Share List by Manufacturers, 2017-2021, in Million USD

Figure Global Production Amount Share by Manufacturers in 2021, in Million USD

4.2.2 Market Concentration Analysis

4.3 Market News and Trend

4.3.1 Merger & Acquisition

4.3.2 New Product Launch

5 Product Type Segment

5.1 Global Overview by Product Type Segment

Table Global Market Status and Growth Rate by Product Type Segment, 2017-2021, in Million USD

Table Global Market Status and Growth Rate by Product Type Segment 2017-2021, in Volume

5.2 Segment Subdivision by Product Type

5.2.1 Market in Xofigo (Radium Ra 223 Dichloride)

5.2.1.1 Market Size

Figure Global Market Amount and Growth Rate in Xofigo (Radium Ra 223 Dichloride), 2017-2021, in USD Million

Figure Global Market Amount and Growth Rate in Xofigo (Radium Ra 223 Dichloride), 2017-2021, in Volume

5.2.1.2 Situation & Development

5.2.2 Market in Jevtana (Cabazitaxel)

5.2.2.1 Market Size

Figure Global Market Amount and Growth Rate in Jevtana (Cabazitaxel), 2017-2021, in USD Million

Figure Global Market Amount and Growth Rate in Jevtana (Cabazitaxel), 2017-2021, in Volume

5.2.2.2 Situation & Development

5.2.3 Market in Inlyta (Axitinib)

5.2.3.1 Market Size

Figure Global Market Amount and Growth Rate in Inlyta (Axitinib), 2017-2021, in USD Million

Figure Global Market Amount and Growth Rate in Inlyta (Axitinib), 2017-2021, in Volume

5.2.3.2 Situation & Development

5.2.4 Market in Votrient (Pazopanib Hydrochloride)

5.2.4.1 Market Size

Figure Global Market Amount and Growth Rate in Votrient (Pazopanib Hydrochloride), 2017-2021, in USD Million

Figure Global Market Amount and Growth Rate in Votrient (Pazopanib Hydrochloride), 2017-2021, in Volume

5.2.4.2 Situation & Development

5.2.5 Market in Sutent (Sunitinib Malate)

5.2.5.1 Market Size

Figure Global Market Amount and Growth Rate in Sutent (Sunitinib Malate), 2017-2021, in USD Million

Figure Global Market Amount and Growth Rate in Sutent (Sunitinib Malate), 2017-2021, in Volume

5.2.5.2 Situation & Development

5.2.6 Market in Zytiga (Abiraterone Acetate)

5.2.6.1 Market Size

Figure Global Market Amount and Growth Rate in Zytiga (Abiraterone Acetate), 2017-2021, in USD Million

Figure Global Market Amount and Growth Rate in Zytiga (Abiraterone Acetate), 2017-2021, in Volume

5.2.6.2 Situation & Development

5.2.7 Market in Xtandi (Enzalutamide)

5.2.7.1 Market Size

Figure Global Market Amount and Growth Rate in Xtandi (Enzalutamide), 2017-2021, in USD Million

Figure Global Market Amount and Growth Rate in Xtandi (Enzalutamide), 2017-2021, in Volume

5.2.7.2 Situation & Development

5.2.8 Market in Opdivo (Nivolumab)

5.2.8.1 Market Size

Figure Global Market Amount and Growth Rate in Opdivo (Nivolumab), 2017-2021, in USD Million

Figure Global Market Amount and Growth Rate in Opdivo (Nivolumab), 2017-2021, in Volume

5.2.8.2 Situation & Development

5.2.9 Market in Provenge (Sipuleucel-T)

5.2.9.1 Market Size

Figure Global Market Amount and Growth Rate in Provenge (Sipuleucel-T), 2017-2021, in USD Million

Figure Global Market Amount and Growth Rate in Provenge (Sipuleucel-T), 2017-2021, in Volume

5.2.9.2 Situation & Development

6 End-Use Segment

6.1 Global Overview by End-Use Segment

Table Global Market Status and Growth Rate by End-Use Segment, 2017-2021, in Million USD

Table Global Market Status and Growth Rate by End-Use Segment 2017-2021, in Volume

6.2 Segment Subdivision

6.2.1 Market in Prostate Cancer

6.2.1.1 Market Size

Figure Global Market Amount and Growth Rate in Prostate Cancer, 2017-2021, in USD Million

Figure Global Market Amount and Growth Rate in Prostate Cancer, 2017-2021, in Volume

6.2.1.2 Situation & Development

6.2.2 Market in Bladder Cancer

6.2.2.1 Market Size

Figure Global Market Amount and Growth Rate in Bladder Cancer, 2017-2021, in USD Million

Figure Global Market Amount and Growth Rate in Bladder Cancer, 2017-2021, in Volume

6.2.2.2 Situation & Development

6.2.3 Market in Kidney Cancer

6.2.3.1 Market Size

Figure Global Market Amount and Growth Rate in Kidney Cancer, 2017-2021, in USD Million

Figure Global Market Amount and Growth Rate in Kidney Cancer, 2017-2021, in Volume

6.2.3.2 Situation & Development

6.2.4 Market in Testicular Cancer

6.2.4.1 Market Size

Figure Global Market Amount and Growth Rate in Testicular Cancer, 2017-2021, in USD Million

Figure Global Market Amount and Growth Rate in Testicular Cancer, 2017-2021, in Volume

6.2.4.2 Situation & Development

7 Market Forecast & Trend

7.1 Regional Forecast

Table Global Market Forecast by Region Segment 2022-2027, in Million USD

Table Global Market Forecast by Region Segment 2022-2027, in Volume

7.2 Consumption Forecast

7.2.1 Product Type Forecast

Table Global Market Amount by Product Type Segment 2022-2027, in Million USD

Table Global Market Volume by Product Type Segment 2022-2027, in Volume

7.2.2 End-Use Forecast

Table Global Market Amount by End-Use Segment 2022-2027, in Million USD

Table Global Market Volume by End-Use Segment 2022-2027, in Volume

7.3 Investment Trend

7.4 Consumption Trend

8 Price & Channel

8.1 Price and Cost

8.1.1 Price

8.1.2 Cost

Figure Cost Component Ratio

8.2 Channel Segment

9 Market Drivers & Investment Environment

9.1 Market Drivers

9.2 Investment Environment

9.3 Impact of Coronavirus on the Urological Cancer Drugs Industry

9.3.1 Impact on Industry Upstream

9.3.2 Impact on Industry Downstream

9.3.3 Impact on Industry Channels

9.3.4 Impact on Industry Competition

9.3.5 Impact on Industry Employment

10 Research Conclusion

If you have any special requirements, please let us know and we will offer you the report as you want.

Fact & Figures

Table Global Market Size and Forecast by Geography with Growth Rate, 2017-2027

Table Global Market Size and Forecast by Type with Growth Rate, 2017-2027

Table Global Market Size and Forecast by End-Use with Growth Rate, 2017-2027

Table Global Production Volume Status and Growth Rate by Geography, 2017-2021, in Volume

Table Global Production Amount Status and Growth Rate by Geography, 2017-2021, in Million USD

Table Global Market Volume and Growth Rate by Geography, 2017-2021, in Volume

Table Global Market Amount and Growth Rate by Geography, 2017-2021, in Million USD

Table Asia-Pacific Production Volume Status and Growth Rate by Region, 2017-2021, in Volume

Table Asia-Pacific Production Amount Status and Growth Rate by Region, 2017-2021, in Million USD

Table North America Production Volume Status and Growth Rate by Region, 2017-2021, in Volume

Table North America Production Amount Status and Growth Rate by Region, 2017-2021, in Million USD

Table South America Production Volume Status and Growth Rate by Region, 2017-2021, in Volume

Table South America Production Amount Status and Growth Rate by Region, 2017-2021, in Million USD

Table Europe Production Volume Status and Growth Rate by Region, 2017-2021, in Volume

Table Europe Production Amount Status and Growth Rate by Region, 2017-2021, in Million USD

Table Middle East & Africa Production Volume Status and Growth Rate by Region, 2017-2021, in Volume

Table Middle East & Africa Production Amount Status and Growth Rate by Region, 2017-2021, in Million USD

Table Asia-Pacific Market Volume and Growth Rate by Region, 2017-2021, in Volume

Table Asia-Pacific Market Amount and Growth Rate by Region, 2017-2021, in Million USD

Table North America Market Volume and Growth Rate by Region, 2017-2021, in Volume

Table North America Market Amount and Growth Rate by Region, 2017-2021, in Million USD

Table South America Market Volume and Growth Rate by Region, 2017-2021, in Volume

Table South America Market Amount and Growth Rate by Region, 2017-2021, in Million USD

Table Europe Market Volume and Growth Rate by Region, 2017-2021, in Volume

Table Europe Market Amount and Growth Rate by Region, 2017-2021, in Million USD

Table Middle East & Africa Market Volume and Growth Rate by Region, 2017-2021, in Volume

Table Middle East & Africa Market Amount and Growth Rate by Region, 2017-2021, in Million USD

Table Major Manufacturers Headquarters and Contact Information

Table Major Manufacturers Capacity List in 2021

Table Novartis Overview List

Table Urological Cancer Drugs Business Operation of Novartis (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)

Table Pfizer Overview List

Table Urological Cancer Drugs Business Operation of Pfizer (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)

Table Johnson & Johnson Overview List

Table Urological Cancer Drugs Business Operation of Johnson & Johnson (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)

Table AstraZeneca Overview List

Table Urological Cancer Drugs Business Operation of AstraZeneca (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)

Table Astellas Overview List

Table Urological Cancer Drugs Business Operation of Astellas (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)

Table Bristol-Myers Squibb Overview List

Table Urological Cancer Drugs Business Operation of Bristol-Myers Squibb (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)

Table Abbott Laboratories Overview List

Table Urological Cancer Drugs Business Operation of Abbott Laboratories (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)

Table Celgene Corporation Overview List

Table Urological Cancer Drugs Business Operation of Celgene Corporation (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)

Table Dendreon Corporation Overview List

Table Urological Cancer Drugs Business Operation of Dendreon Corporation (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)

Table Ferring Pharmaceuticals Overview List

Table Urological Cancer Drugs Business Operation of Ferring Pharmaceuticals (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)

Table GlaxoSmithKline Overview List

Table Urological Cancer Drugs Business Operation of GlaxoSmithKline (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)

Table Indevus Pharmaceuticals Inc Overview List

Table Urological Cancer Drugs Business Operation of Indevus Pharmaceuticals Inc (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)

Table Ipsen Overview List

Table Urological Cancer Drugs Business Operation of Ipsen (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)

Table Roche Healthcare Overview List

Table Urological Cancer Drugs Business Operation of Roche Healthcare (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)

Table Sanofi S.A. Overview List

Table Urological Cancer Drugs Business Operation of Sanofi S.A. (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)

Table Tolmar Inc Overview List

Table Urological Cancer Drugs Business Operation of Tolmar Inc (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)

Table Global Production Volume List by Manufacturers, 2017-2021, in Volume

Table Global Production Volume Share List by Manufacturers, 2017-2021, in Volume

Table Global Production Amount List by Manufacturers, 2017-2021, in Million USD

Table Global Production Amount Share List by Manufacturers, 2017-2021, in Million USD

Table Global Market Status and Growth Rate by Product Type Segment, 2017-2021, in Million USD

Table Global Market Status and Growth Rate by Product Type Segment 2017-2021, in Volume

Table Global Market Status and Growth Rate by End-Use Segment, 2017-2021, in Million USD

Table Global Market Status and Growth Rate by End-Use Segment 2017-2021, in Volume

Table Global Market Forecast by Region Segment 2022-2027, in Million USD

Table Global Market Forecast by Region Segment 2022-2027, in Volume

Table Global Market Amount by Product Type Segment 2022-2027, in Million USD

Table Global Market Volume by Product Type Segment 2022-2027, in Volume

Table Global Market Amount by End-Use Segment 2022-2027, in Million USD

Table Global Market Volume by End-Use Segment 2022-2027, in Volume

List of Figure

Figure Urological Cancer Drugs Picture List

Figure Global Market Size and Forecast with Growth Rate, 2017-2027

Figure Global Production Volume Status and Growth Rate, 2017-2021, in Volume

Figure Global Production Amount Status and Growth Rate, 2017-2021, in Million USD

Figure Global Market Volume and Growth Rate, 2017-2021, in Volume

Figure Global Market Amount and Growth Rate, 2017-2021, in Million USD

Figure Asia-Pacific Production Volume Status and Growth Rate, 2017-2021, in Volume

Figure Asia-Pacific Production Amount Status and Growth Rate, 2017-2021, in Million USD

Figure North America Production Volume Status and Growth Rate, 2017-2021, in Volume

Figure North America Production Amount Status and Growth Rate, 2017-2021, in Million USD

Figure South America Production Volume Status and Growth Rate, 2017-2021, in Volume

Figure South America Production Amount Status and Growth Rate, 2017-2021, in Million USD

Figure Europe Production Volume Status and Growth Rate, 2017-2021, in Volume

Figure Europe Production Amount Status and Growth Rate, 2017-2021, in Million USD

Figure Middle East & Africa Production Volume Status and Growth Rate, 2017-2021, in Volume

Figure Middle East & Africa Production Amount Status and Growth Rate, 2017-2021, in Million USD

Figure Asia-Pacific Market Volume and Growth Rate, 2017-2021, in Volume

Figure Asia-Pacific Market Amount and Growth Rate, 2017-2021, in Million USD

Figure North America Market Volume and Growth Rate, 2017-2021, in Volume

Figure North America Market Amount and Growth Rate, 2017-2021, in Million USD

Figure South America Market Volume and Growth Rate, 2017-2021, in Volume

Figure South America Market Amount and Growth Rate, 2017-2021, in Million USD

Figure Europe Market Volume and Growth Rate, 2017-2021, in Volume

Figure Europe Market Amount and Growth Rate, 2017-2021, in Million USD

Figure Middle East & Africa Market Volume and Growth Rate, 2017-2021, in Volume

Figure Middle East & Africa Market Amount and Growth Rate, 2017-2021, in Million USD

Figure Global Market Size and Growth Rate, 2017-2021, in Volume

Figure Global Market Size and Growth Rate, 2017-2021, in Million USD

Figure Global Competition Sketch Overview

Figure Global Production Volume Share by Manufacturers in 2021, in Volume

Figure Global Production Amount Share by Manufacturers in 2021, in Million USD

Figure Global Market Amount and Growth Rate in Xofigo (Radium Ra 223 Dichloride), 2017-2021, in USD Million

Figure Global Market Amount and Growth Rate in Xofigo (Radium Ra 223 Dichloride), 2017-2021, in Volume

Figure Global Market Amount and Growth Rate in Jevtana (Cabazitaxel), 2017-2021, in USD Million

Figure Global Market Amount and Growth Rate in Jevtana (Cabazitaxel), 2017-2021, in Volume

Figure Global Market Amount and Growth Rate in Inlyta (Axitinib), 2017-2021, in USD Million

Figure Global Market Amount and Growth Rate in Inlyta (Axitinib), 2017-2021, in Volume

Figure Global Market Amount and Growth Rate in Votrient (Pazopanib Hydrochloride), 2017-2021, in USD Million

Figure Global Market Amount and Growth Rate in Votrient (Pazopanib Hydrochloride), 2017-2021, in Volume

Figure Global Market Amount and Growth Rate in Sutent (Sunitinib Malate), 2017-2021, in USD Million

Figure Global Market Amount and Growth Rate in Sutent (Sunitinib Malate), 2017-2021, in Volume

Figure Global Market Amount and Growth Rate in Zytiga (Abiraterone Acetate), 2017-2021, in USD Million

Figure Global Market Amount and Growth Rate in Zytiga (Abiraterone Acetate), 2017-2021, in Volume

Figure Global Market Amount and Growth Rate in Xtandi (Enzalutamide), 2017-2021, in USD Million

Figure Global Market Amount and Growth Rate in Xtandi (Enzalutamide), 2017-2021, in Volume

Figure Global Market Amount and Growth Rate in Opdivo (Nivolumab), 2017-2021, in USD Million

Figure Global Market Amount and Growth Rate in Opdivo (Nivolumab), 2017-2021, in Volume

Figure Global Market Amount and Growth Rate in Provenge (Sipuleucel-T), 2017-2021, in USD Million

Figure Global Market Amount and Growth Rate in Provenge (Sipuleucel-T), 2017-2021, in Volume

Figure Global Market Amount and Growth Rate in Prostate Cancer, 2017-2021, in USD Million

Figure Global Market Amount and Growth Rate in Prostate Cancer, 2017-2021, in Volume

Figure Global Market Amount and Growth Rate in Bladder Cancer, 2017-2021, in USD Million

Figure Global Market Amount and Growth Rate in Bladder Cancer, 2017-2021, in Volume

Figure Global Market Amount and Growth Rate in Kidney Cancer, 2017-2021, in USD Million

Figure Global Market Amount and Growth Rate in Kidney Cancer, 2017-2021, in Volume

Figure Global Market Amount and Growth Rate in Testicular Cancer, 2017-2021, in USD Million

Figure Global Market Amount and Growth Rate in Testicular Cancer, 2017-2021, in Volume

Figure Cost Component Ratio

If you have any special requirements, please let us know and we will offer you the report as you want.

Please share youre basic details, to recieve the report sample

If you have any special requirements, please let us know and we will offer you the report as you want.

Our Clients

dropbox
kodak
honeywell
philips
nestle
Hanwha
Compass-Minerals
Elanco
Honda-Europe
Courant.Biz | Powered By SAIME DIGITAL TECHNOLOGIES PVT. LTD. | © 2020